Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
IPHA
Stock Latest News
The Fly
Innate Pharma presents long-term follow-up data from TELLOMAK trial
16d ago
IPHA
Premium
Ratings
Innate Pharma: Navigating Challenges with Promising Pipeline and Strategic Partnerships
1M ago
IPHA
Premium
The Fly
Innate Pharma price target lowered to $11 from $11.50 at H.C. Wainwright
1M ago
IPHA
Premium
The Fly
Innate Pharma announces EUR 15M capital increase from Sanofi
1M ago
SNY
IPHA
Premium
The Fly
Innate Pharma regains rights to Anket, announces potential Sanofi investment
2M ago
SNY
IPHA
Premium
Ratings
Innate Pharma: Promising Pipeline and Strategic Developments Drive Buy Rating
2M ago
IPHA
Premium
Company Announcements
Innate Pharma Reports 2024 Financial Results and Clinical Progress
2M ago
IPHA
Premium
Ratings
Buy Rating for Innate Pharma: Lacutamab’s Breakthrough Designation and Market Potential Drive Positive Outlook
4M ago
IPHA
Premium
Ratings
Innovative Potential of Innate Pharma’s IPH4502 in Overcoming Drug Resistance and Expanding Therapeutic Impact
4M ago
IPHA
Premium
The Fly
Innate Pharma doses first patient in IPH4502 study
4M ago
IPHA
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
VIR
BCYC
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
KOD
AGIO
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
KOD
AGIO
Premium
The Fly
Innate Pharma announces new data from TELLOMAK study
6M ago
IPHA
Premium
The Fly
Innate Pharma partners with IFLI to study IPH6501, to receive $3M upfront
6M ago
IPHA
Premium
The Fly
Innate Pharma publishes IPH6501 data in Science Immunology
7M ago
IPHA
Premium
The Fly
Innate Pharma appoints Jonathan Dickinson as CEO
8M ago
INCY
IPHA
Premium
The Fly
Innate Pharma announces FDA clearance of IPH4502 IND
9M ago
IPHA
Premium
The Fly
Innate Pharma reports AstraZeneca presentation of results from NeoCOAST-2 study
9M ago
AZN
IPHA
Premium
The Fly
Innate Pharma announces updated results from SAR443579/IPH6101
12M ago
SNY
IPHA
Premium
The Fly
Innate Pharma announces results from TELLOMAK study
1y ago
IPHA
Premium
The Fly
Innate Pharma provides clarification regarding SAR443579 designation
1y ago
SNY
IPHA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
